NCT06925360View on ClinicalTrials.gov

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Bronchopulmonary Dysplasia
Interventions
DRUG

intravenous immunoglobulin

1 g/kg/day for the first 2 days, 0.5 g/kg/day for next 3 days (total does 3.5 g/kg), repeatable 1\~2 times if necessary (5 days after the last infusion).

Trial Locations (1)

Unknown

RECRUITING

International Peace Maternity and Child Health Hospital, Shanghai

All Listed Sponsors
lead

International Peace Maternity and Child Health Hospital

OTHER